Pfizer Inc. has acquired exclusive rights to commercialize an obesity therapy in China, strengthening its push into the fast-growing weight loss market.
www.bloomberg.com
#Pfizer #Secures #China #Rights #Obesity #Drug #Million #Deal
Pfizer Secures China Rights to Obesity Drug in $495 Million Deal
